Exclusive Features

Medxtractor Looks to Transform Mobile Health with Machine-Learning

Machine-Learning (“ML”) (sometimes referred to as artificial intelligence or “AI”) has experienced a renaissance over the past five years thanks to a combination of big data, fast processors, and new…

How to Invest in Psychedelics

The psychedelics industry is following in the same projectile footsteps of the cannabis industry and could be on its way to becoming a multi-billion dollar industry. With the potential to…

Exclusive Features

Microdosing: The Next Revolution in Psychedelics

The psychedelics industry has experienced a renaissance over the past few years as researchers have opened a pandora’s box of potential. From major depression to generalized anxiety to post-traumatic stress…

Psychedelics Then & Now: From Ancient Times to the Psychedelic Renaissance

Psychedelics have become one of the most promising classes of drugs in a generation, as well as an exciting new industry for investors. Despite their resurgence among researchers and investors,…

Exclusive Features

What Revive’s PharmaTher Acquisition Means for Investors

Revive Therapeutics Ltd. (CSE: RVV) (OTC: RVVTF) recently acquired the full rights to PharmaTher Inc.’s (CSE: PHRM) (OTC: PHRRF) intellectual property pertaining to psilocybin—the most popular psychedelic compound in clinical…

Exclusive Features

Delic’s Vision Comes Into Focus With a Flurry of Acquisitions

Investors have many different options when it comes to building exposure into the psychedelics sector within their portfolios. While some companies are undergoing large-scale and years-long clinical trials to prove…